Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2011-06-10 19:02:15
Reporting Period:
Filing Date:
Accepted Time:
2011-06-10 18:02:15
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1410471 Ipc The Hospitalist Company Inc. IPCM Services-Misc Health & Allied Services, Nec (8090) 954562058
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1424036 G Devra Shapiro C/o Ipc The Hospitalist Company, Inc.
4605 Lankershim Blvd., Ste 617
North Hollywood CA 91602
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-06-08 5,000 $5.25 7,700 No 4 M Direct
Common Stock Disposition 2011-06-08 5,000 $46.60 2,700 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right-to-Buy) Disposition 2011-06-08 5,000 $0.00 5,000 $5.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,565 2017-07-19 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 48,512 Indirect The Alan and Devra Shapiro Trust
  1. The option execise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2011.
  2. The sale price represnets the weighted average sale price of the shares sold ranging from $49.29 to $46.80.
  3. Amount includes 2,700 shares of Common Stock subject to unvested Restricted Stock Grant.
  4. Options were granted on July 19, 2007. 25% of the options vest twelve months after the anniversary of the grant date. The remainder will vest in equal amounts monthly over the subsequent 36 months.